Tarveda Therapeutics
AcquiredWatertown, United States · $68.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Total Funding
- $68.0M
- Last Round
- $30.0M Series DFeb 2017
- Rounds
- 2
About
Clinical-stage biotech developing Pentarin miniature drug conjugates targeting solid tumors for cancer treatment.
Summary
Tarveda Therapeutics is a Biotech company based in Watertown, United States. It has raised $68.0M in total across 2 rounds, most recently a $30.0M Series D round in Feb 2017. Investors include Novo Holdings A/S, Jerel Davis and New Enterprise Associates.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2017
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...